Search Results - "VISCONTE, Valeria"

Refine Results
  1. 1
  2. 2

    Capturing the unpredictability of stem cells by Durmaz, Arda, Visconte, Valeria

    Published in eLife (01-03-2024)
    “…A new mathematical model that can be applied to both single-cell and bulk DNA sequencing data sheds light on the processes governing population dynamics in…”
    Get full text
    Journal Article
  3. 3

    Deciphering the Therapeutic Resistance in Acute Myeloid Leukemia by Gurnari, Carmelo, Pagliuca, Simona, Visconte, Valeria

    “…Acute myeloid leukemia (AML) is a clonal hematopoietic disorder characterized by abnormal proliferation, lack of cellular differentiation, and infiltration of…”
    Get full text
    Journal Article
  4. 4

    KMT2A Rearrangements in Leukemias: Molecular Aspects and Therapeutic Perspectives by Guarnera, Luca, D'Addona, Matteo, Bravo-Perez, Carlos, Visconte, Valeria

    “…(alias: mixed-lineage leukemia [ ]) gene mapping on chromosome 11q23 encodes the lysine-specific histone N-methyltransferase 2A and promotes transcription by…”
    Get full text
    Journal Article
  5. 5

    The Interactome between Metabolism and Gene Mutations in Myeloid Malignancies by Gurnari, Carmelo, Pagliuca, Simona, Visconte, Valeria

    “…The study of metabolic deregulation in myeloid malignancies has led to the investigation of metabolic-targeted therapies considering that cells undergoing…”
    Get full text
    Journal Article
  6. 6

    Disruption of Autophagic Degradation with ROC-325 Antagonizes Renal Cell Carcinoma Pathogenesis by Carew, Jennifer S, Espitia, Claudia M, Zhao, William, Han, Yingchun, Visconte, Valeria, Phillips, James, Nawrocki, Steffan T

    Published in Clinical cancer research (01-06-2017)
    “…Although autophagy plays important roles in malignant pathogenesis and drug resistance, there are few clinical agents that disrupt this pathway, and the…”
    Get full text
    Journal Article
  7. 7

    Personalized Risk Schemes and Machine Learning to Empower Genomic Prognostication Models in Myelodysplastic Syndromes by Awada, Hussein, Gurnari, Carmelo, Durmaz, Arda, Awada, Hassan, Pagliuca, Simona, Visconte, Valeria

    “…Myelodysplastic syndromes (MDS) are characterized by variable clinical manifestations and outcomes. Several prognostic systems relying on clinical factors and…”
    Get full text
    Journal Article
  8. 8

    Individual HLA heterogeneity and its implications for cellular immune evasion in cancer and beyond by Pagliuca, Simona, Gurnari, Carmelo, Rubio, Marie Thérèse, Visconte, Valeria, Lenz, Tobias L.

    Published in Frontiers in immunology (05-09-2022)
    “…Structural and functional variability of human leukocyte antigen (HLA) is the foundation for competent adaptive immune responses against pathogen and tumor…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis by Makishima, Hideki, Visconte, Valeria, Sakaguchi, Hirotoshi, Jankowska, Anna M., Abu Kar, Sarah, Jerez, Andres, Przychodzen, Bartlomiej, Bupathi, Manoj, Guinta, Kathryn, Afable, Manuel G., Sekeres, Mikkael A., Padgett, Richard A., Tiu, Ramon V., Maciejewski, Jaroslaw P.

    Published in Blood (05-04-2012)
    “…Myelodysplastic syndromes (MDSs) are chronic and often progressive myeloid neoplasms associated with remarkable heterogeneity in the histomorphology and…”
    Get full text
    Journal Article
  11. 11

    Immunotherapy in Acute Myeloid Leukemia: A Literature Review of Emerging Strategies by Guarnera, Luca, Bravo-Perez, Carlos, Visconte, Valeria

    Published in Bioengineering (Basel) (01-10-2023)
    “…In the last twenty years, we have witnessed a paradigm shift in the treatment and prognosis of acute myeloid leukemia (AML), thanks to the introduction of new…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Rational management approach to pure red cell aplasia by Balasubramanian, Suresh Kumar, Sadaps, Meena, Thota, Swapna, Aly, Mai, Przychodzen, Bartlomiej P, Hirsch, Cassandra M, Visconte, Valeria, Radivoyevitch, Tomas, Maciejewski, Jaroslaw P

    Published in Haematologica (Roma) (01-02-2018)
    “…Pure red cell aplasia is an orphan disease, and as such lacks rationally established standard therapies. Most cases are idiopathic; a subset is…”
    Get full text
    Journal Article
  15. 15

    Therapy-Related Myeloid Neoplasm: Biology and Mechanistic Aspects of Malignant Progression by Travaglini, Serena, Marinoni, Massimiliano, Visconte, Valeria, Guarnera, Luca

    Published in Biomedicines (01-05-2024)
    “…Therapy-related myeloid neoplasms (t-MN) arise after a documented history of chemo/radiotherapy as treatment for an unrelated condition and account for 10-20%…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    The Genomics of Myelodysplastic Syndromes: Origins of Disease Evolution, Biological Pathways, and Prognostic Implications by Awada, Hassan, Thapa, Bicky, Visconte, Valeria

    Published in Cells (Basel, Switzerland) (20-11-2020)
    “…The molecular pathogenesis of myelodysplastic syndrome (MDS) is complex due to the high rate of genomic heterogeneity. Significant advances have been made in…”
    Get full text
    Journal Article
  19. 19
  20. 20